✦ LIBER ✦

Carfilzomib: A new proteasome inhibitor for relapsed or refractory multiple myeloma

✍ Scribed by Steele, J. M.

Book ID: 127251949
Publisher: SAGE Publications
Year: 2013
Tongue: English
Weight: 132 KB
Volume: 19
Category: Article
ISSN: 1078-1552
DOI: 10.1177/1078155212470388

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carfilzomib: A Second-Generation Proteas

Carfilzomib: A Second-Generation Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma

✍ Thompson, J. L. 📂 Article 📅 2013 🏛 Harvey Whitney Books Company 🌐 English ⚖ 152 KB

New hope for relapsed and refractory mul

New hope for relapsed and refractory multiple myeloma

✍ Leleu, Xavier 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 317 KB

High-dose dexamethasone for refractory o

High-dose dexamethasone for refractory or relapsing multiple myeloma

✍ William R. Friedenberg; Robert A. Kyle; William H. Knospe; John M. Bennett; Anas 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 1 views

Thalidomide with or without dexamethason

Thalidomide with or without dexamethasone for refractory or relapsing multiple myeloma

✍ Raymond Alexanian; Donna Weber; Athanasios Anagnostopoulos; Kay Delasalle; Micha 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Emerging therapies for the treatment of

Emerging therapies for the treatment of relapsed or refractory multiple myeloma

✍ Meletios A. Dimopoulos; Jesus F. San-Miguel; Kenneth C. Anderson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

Lenalidomide is effective for extramedul

Lenalidomide is effective for extramedullary disease in relapsed or refractory multiple myeloma

✍ José M. Calvo-Villas; Adrián Alegre; Carmen Calle; Miguel T. Hernández; Ricarda 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB